These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25961532)

  • 21. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.
    Künstlinger H; Binot E; Merkelbach-Bruse S; Huss S; Wardelmann E; Buettner R; Schildhaus HU
    Hum Pathol; 2014 Mar; 45(3):573-82. PubMed ID: 24444465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient with high-risk GIST not associated with c-KIT mutations: same benefit from adjuvant therapy?
    Izquierdo ME; Bonastre MT
    Anticancer Drugs; 2012 Jun; 23 Suppl():S7-9. PubMed ID: 22739668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations.
    Osuch C; Rutkowski P; Brzuszkiewicz K; Bylina E; Limon J; Siedlecki JA
    Pol Przegl Chir; 2014 Jul; 86(7):325-32. PubMed ID: 25222580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational insights into gastrointestinal stromal tumor and current clinical advances.
    Hemming ML; Heinrich MC; Bauer S; George S
    Ann Oncol; 2018 Oct; 29(10):2037-2045. PubMed ID: 30101284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.
    Boikos SA; Stratakis CA
    Endocrine; 2014 Nov; 47(2):401-8. PubMed ID: 25027296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].
    Bettegazzi C; Erra S
    Recenti Prog Med; 2015 Jan; 106(1):52-7. PubMed ID: 25621782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelioid variant of gastrointestinal stromal tumor harboring PDGFRA mutation and MLH1 gene alteration: A case report.
    Kobayashi M; Inaguma S; Raffeld M; Kato H; Suzuki S; Wakasugi T; Mitsui A; Kuwabara Y; Lasota J; Ikeda H; Miettinen M; Takahashi S
    Pathol Int; 2019 Sep; 69(9):541-546. PubMed ID: 31273885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting Secondary C-KIT Mutations in the Peripheral Blood of Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor.
    Wada N; Kurokawa Y; Takahashi T; Hamakawa T; Hirota S; Naka T; Miyazaki Y; Makino T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Oncology; 2016; 90(2):112-7. PubMed ID: 26779618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations.
    Floris G; Sciot R; Wozniak A; Van Looy T; Wellens J; Faa G; Normant E; Debiec-Rychter M; Schöffski P
    Clin Cancer Res; 2011 Sep; 17(17):5604-14. PubMed ID: 21737509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
    Hemming ML; Lawlor MA; Andersen JL; Hagan T; Chipashvili O; Scott TG; Raut CP; Sicinska E; Armstrong SA; Demetri GD; Bradner JE
    Cancer Res; 2019 Mar; 79(5):994-1009. PubMed ID: 30630822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histology and molecular biology of GIST].
    Emile JF
    Bull Acad Natl Med; 2012; 196(4-5):835-44. PubMed ID: 23550446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple gastrointestinal stromal tumors caused by a novel germline KIT gene mutation (Asp820Gly): a case report and literature review.
    Arima J; Hiramatsu M; Taniguchi K; Kobayashi T; Tsunematsu I; Kagota S; Sakane J; Suzuki Y; Hirota S
    Gastric Cancer; 2020 Jul; 23(4):760-764. PubMed ID: 32146645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.
    Garner AP; Gozgit JM; Anjum R; Vodala S; Schrock A; Zhou T; Serrano C; Eilers G; Zhu M; Ketzer J; Wardwell S; Ning Y; Song Y; Kohlmann A; Wang F; Clackson T; Heinrich MC; Fletcher JA; Bauer S; Rivera VM
    Clin Cancer Res; 2014 Nov; 20(22):5745-5755. PubMed ID: 25239608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
    Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
    Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors.
    Serrano C; Bauer S
    Curr Oncol Rep; 2022 Feb; 24(2):151-159. PubMed ID: 35061196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H.
    Revheim ME; Kristian A; Malinen E; Bruland ØS; Berner JM; Holm R; Joensuu H; Seierstad T
    Acta Oncol; 2013 May; 52(4):776-82. PubMed ID: 23480638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.
    Ito T; Yamamura M; Hirai T; Ishikawa T; Kanda T; Nakai T; Ohkouchi M; Hashikura Y; Isozaki K; Hirota S
    Int J Clin Exp Pathol; 2014; 7(11):8024-31. PubMed ID: 25550846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New drug approvals: Ripretinib for advanced gastrointestinal stromal tumors (GIST) in fourth or later-line therapy].
    Lemaître J; Watson S
    Bull Cancer; 2022 Mar; 109(3):250-252. PubMed ID: 35094842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.